阿昔利定盐酸盐,CAS 登记号 6109-70-2,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于医药中间体及原料药。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
医药中间体及原料药
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 阿昔利定盐酸盐 的 CAS 号:6109-70-2,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及医药中间体及原料药。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
Aceclidine, Hydrochloride · CAS 6109-70-2 · C9H16ClNO2. UNII 3B22O325Q6.
| CAS Registry Number | 6109-70-2 |
|---|---|
| PubChem CID | 170367 |
| Molecular formula | C9H16ClNO2 |
| IUPAC name | 1-azabicyclo[2.2.2]octan-3-yl acetate;hydrochloride |
| UNII (FDA) | 3B22O325Q6 |
| Molecular Weight | 205.68 |
|---|---|
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 205.0869564 |
| Monoisotopic Mass | 205.0869564 |
| Topological Polar Surface Area | 29.5 |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 185 |
| Reported hazard statements | H301 (100%), H311 (95.1%) |
|---|
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
H311 (95.1%): Toxic in contact with skin [Danger Acute toxicity, dermal]
Aceclidine hydrochloride; 6109-70-2; Aceclidine HCl; 3-Acetoxyquinuclidine hydrochloride; C 162 D; 3B22O325Q6; 1-Azabicyclo(2.2.2)octan-3-ol, acetate (ester), hydrochloride; 1-Azabicyclo(2.2.2)octan-3-ol, 3-acetate, hydrochloride (1:1); RefChem:551459; 228-071-5; Quinuclidin-3-yl acetate hydrochloride; Aceclidine (hydrochloride); MFCD00136230; 1-Azabicyclo[2.2.2]oct-3-yl acetate hydrochloride; DTXSID30976587; 1-azabicyclo[2.2.2]octan-3-yl acetate;hydrochloride
CAS 6109-70-2; molecular formula C9H16ClNO2; molecular weight — g/mol.
Aceclidine hydrochloride, 6109-70-2, Aceclidine HCl, 3-Acetoxyquinuclidine hydrochloride, C 162 D, 3B22O325Q6.
Hazard statements reported: H301, H311.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.